佩蒂动物营养科技股份有限公司 投资者关系活动记录表 1 编号：IR2022-005 | --- | --- | --- | |-----------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------| | | | | | | 特定对象调研 | 分析师会议 | | 投资者关系活动 | 媒体采访 | 业绩说明会 | | 类别 | 新闻发布会 | 路演活动 | | | 现场参观 | 其他 | | | 兴业证券：代凯燕 | | | | 广发证券：周舒玥 | | | 参与单位名称及 人员姓名（排名 | 华泰保险：黄佳丽 蜂巢基金：王映雪 | | | 无先后） | 上海世诚投资：邹文俊 | | | | 兴银理财：王毅成 | | | ...

佩蒂动物营养科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |-------------------------|----------------|-------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...

佩蒂动物营养科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |--------------------------------|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------| | | | 特定对象调研 | 分析师会议 | | 投资者关系活 | | 媒体采访 | 业绩说明会 | | 动类别 | | 新闻发布会 | 路演活动 | | | ...

佩蒂动物营养科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |-------------------------|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------| | | | 特定对象调研 | 分析师会议 | | 投资者关系 | | 媒体采访 | 业绩说明会 ...

佩蒂动物营养科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | --- | |-------------|-------|-----------------------------------------------------------------------------|-------|------------| | | | 特定对象调研 | | 分析师会议 | | 投资者关 | | 媒体采访 | | 业绩说明会 | | 系活动类 别 | | 新闻发布会 | | 路演活动 | | | | 投资者现场参观、交流 | | 其他 | | 参加的投 | | 登录全景网·路演参加公司本次路演的全体人士，无特定投资者 | | | | 资者 | | | | | | 时间 | 2021 | 年 12 月 21 日 | | | | 现场地点 | | 全景网杭州路演中心、全景网上海路演中心 | | | | | | 董事长、总经理陈振标先生 董事、董事会秘书、财务总监唐照波先生 | | | | 参加人员 | | 保荐代表人：王耀先生、李栋一女士 | | | | | | 全景网提供支持的 ...

佩蒂动物营养科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |-------------------|-------|--------------------------------------------------------------------|------------------------------------| | | | 特定对象调研 | 分析师会议 | | 投资者关 系活动类 | | 媒体采访 | 业绩说明会 | | 别 | | 新闻发布会 | 路演活动 | | | | 投资者现场参观、交流 | 其他 | | | | 国盛证券：李顺帆 孟鑫 | | | | | 恒越基金：郭祝同 | | | 参加的投 资者 | | 长信基金：肖文劲 中银国际证券：叶志成 浦银安盛基金：郑双超 | | | | | | | | 时间 | 2022 | 年 2 月 10 日 | | | 现场地点 | | 浙江省温州市工业园区宠乐路 2 号佩蒂公司 | 3 楼会议室 | | | | | | | 参加人员 | | 董事会秘书唐照波、证券事务代表王海涛 | | | | | ...

佩蒂动物营养科技股份有限公司 投资者关系活动记录表 编号：IR2022-004 | --- | --- | --- | --- | |----------------------------------------|----------------------------------------------------------------------------------------------|----------------------------------------------------------|-------| | | | | | | | 特定对象调研 | 分析师会议 | | | 投资者关系活动 | 媒体采访 | 业绩说明会 | | | 类别 | 新闻发布会 | 路演活动 | | | | 现场参观 | 其他 | | | | | 中信证券：彭家乐、王聪、朱欣頔、李天雄； | | | | 东方红资产：满臻、蔡毓伟； 物产中大：曲芳、林彬彬； | | | | | 慧实基金：楼卉； 凯读投资：辛植钧； | | | | | 重阳投资：陈瑶； | | | | 参与单位名称及 人员姓名（排名 无先后 ...

佩蒂动物营养科技股份有限公司 投资者关系活动记录表 1 编号：IR2022-005 | --- | --- | |-------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | 特定对象调研 分析师会议 | | 投资者关系活动 | 业绩说明会 | | 类别 | 新闻发布会 路演活动 | | | 其他 | | | 安信证券：王朔、夏心怡 | ...

Financial Performance - The company's revenue for Q3 2022 reached ¥508,548,822.17, representing a 149.49% increase year-over-year[2] - Net profit attributable to shareholders was ¥67,463,198.75, a significant increase of 391.48% compared to the same period last year[2] - The basic earnings per share (EPS) for Q3 2022 was ¥0.27, reflecting a 440.00% increase year-over-year[2] - The company reported a 48.01% increase in revenue for the first nine months of 2022, totaling ¥1,354,612,253.13, driven by increased orders[9] - The net profit for Q3 2022 was CNY 160,196,215.57, a 99.4% increase compared to CNY 80,334,005.81 in Q3 2021[26] - Operating profit reached CNY 196,828,023.36, up from CNY 97,199,377.27 in the same period last year, representing a 102.1% increase[26] - Total revenue from operating activities was CNY 1,298,399,712.85, compared to CNY 1,040,577,284.79 in the previous year, indicating a growth of 24.7%[28] - The company reported a basic earnings per share of CNY 0.63, doubling from CNY 0.31 in the same quarter last year[27] - The total comprehensive income for Q3 2022 was CNY 200,349,766.60, compared to CNY 67,226,671.56 in Q3 2021, marking a significant increase[27] Assets and Liabilities - Total assets as of September 30, 2022, amounted to ¥3,093,009,016.72, an increase of 8.34% from the end of the previous year[2] - Total assets increased to RMB 3,093,009,016.72 as of September 30, 2022, up from RMB 2,854,914,479.62 at the beginning of the year[24] - The company's total liabilities reached RMB 1,155,900,872.53, compared to RMB 1,060,409,057.11 in the previous period, indicating an increase of about 9%[24] - The total equity attributable to shareholders increased to RMB 1,919,788,513.89 from RMB 1,779,407,716.39, showing a growth of approximately 7.9%[24] Cash Flow and Investments - The company's cash flow from operating activities showed a net outflow of ¥92,146,216.00, a decrease of 98.36% compared to the previous year[2] - Cash received from investment decreased by 81.82% to ¥2,000,000.00, primarily due to the previous period's equity investment recovery[11] - Cash paid for operating activities increased by 68.76% to ¥17,807,780.37, primarily due to increased interest income[11] - Cash paid for other operating activities rose by 59.70% to ¥120,988,934.43, mainly due to higher period expenses[11] - Cash paid for debt repayment increased by 63.33% to ¥344,132,343.10, primarily due to increased repayment of implicit borrowings[11] - Cash paid for share repurchase activities surged by 358.61% to ¥64,753,047.11, reflecting the company's active buyback strategy[11] - Cash and cash equivalents decreased to RMB 724,633,546.71 from RMB 1,029,586,625.74 at the beginning of the year, representing a decline of approximately 29.6%[22] - Cash and cash equivalents at the end of the period were CNY 723,869,931.71, an increase from CNY 305,622,083.28 year-over-year[29] Shareholder Activities - The total number of common shareholders at the end of the reporting period was 12,694[13] - The company approved the 2022 restricted stock incentive plan and employee stock ownership plan on August 1, 2022[16] - The company granted 2.121 million shares of restricted stock at a price of ¥8.83 per share to 242 eligible participants on August 12, 2022[17] - The company transferred 1.52 million shares to the employee stock ownership plan account on September 7, 2022[18] - The company repurchased a total of 4,028,135 shares, accounting for 1.5895% of the total share capital as of the end of the reporting period, with a total expenditure of RMB 64,742,043.25[19] - As of the end of the reporting period, 1,442 convertible bonds were converted into 8,083 shares, with a total face value of RMB 144,200, while 7,198,470 convertible bonds remain outstanding, totaling RMB 719,847,000.00[20] Operational Costs and Expenses - Total operating costs amounted to RMB 1,142,271,337.47, compared to RMB 829,806,865.76 in the previous period, indicating an increase of about 37.7%[25] - Research and development expenses increased to CNY 20,352,352.73, up from CNY 15,947,702.91, reflecting a growth of 27.5%[26] - The company incurred financial expenses of CNY -55,193,515.87, a notable change from CNY 17,189,539.27 in the previous year[26] Other Financial Metrics - The company's net profit margin improved, with a weighted average return on equity of 3.59% for Q3 2022, up from 2.77% in the previous year[2] - The accounts receivable increased by 119.10% to ¥440,969,393.98, primarily due to higher revenue[6] - The company experienced a 904.64% increase in contract liabilities, reaching ¥5,241,444.42, attributed to increased domestic sales[6] - The company reported a significant increase in government subsidies, totaling ¥1,170,169.70 for the current period[4] - Inventory increased to RMB 481,236,517.16 from RMB 449,749,566.19, reflecting a growth of approximately 7%[23]

Financial Performance - The company reported a revenue of RMB 500 million for the first half of 2022, representing a year-on-year increase of 15%[16]. - The gross profit margin for the period was 30%, which is a slight decrease from 32% in the same period last year[16]. - The company's operating revenue for the first half of 2022 was ¥846,063,430.96, representing an increase of 18.93% compared to the same period last year[22]. - The net profit attributable to shareholders was ¥90,437,944.59, reflecting a growth of 39.23% year-over-year[22]. - The net profit after deducting non-recurring gains and losses was ¥93,039,797.21, which is a 49.61% increase compared to the previous year[22]. - The basic earnings per share increased to ¥0.36, up 38.46% from ¥0.26 in the same period last year[22]. - The company reported a total revenue of 26,535 million RMB for the first half of 2022, reflecting a growth of 2.05% compared to the previous year[94]. - The company reported a significant increase in income tax expenses by 56.97% to CNY 20,625,611.05, mainly due to increased profits[77]. - The net cash flow from operating activities decreased by 50.70% to CNY -114,545,390.60, primarily due to increased strategic inventory of raw materials[77]. Investment and Development - The company plans to invest RMB 100 million in new product development and technology research in the upcoming year[16]. - The total investment amount for the reporting period reached ¥410,111,500, a significant increase of 666.98% compared to ¥53,470,800 in the same period last year[84]. - The company has committed to projects with a total investment of ¥13,078 million, with ¥6,578 million already invested[92]. - The company is focusing on the development of new products, with a significant investment in R&D projects amounting to 3,964 million[93]. - The company has established a professional R&D team and invested significantly in areas such as raw material processing, product technology, and pet nutrition, aiming to enhance production efficiency and reduce costs[35]. Market Strategy and Expansion - The company has outlined a market expansion strategy targeting Southeast Asia, aiming for a 10% market share by 2025[16]. - The company is exploring potential acquisitions to enhance its product portfolio and market presence[16]. - The company has established multiple production lines for various pet food products, including meat snacks and dry/wet food, contributing to stable revenue growth in recent years[61]. - The company is expanding its production capacity in Cambodia to 2,000 tons of pet leisure food, with a completion target set for 2023[93]. - The company is targeting a market expansion in Vietnam, with a projected output of 5,000 tons for its new production line[93]. Risk Management - The company faces risks related to supply chain disruptions and has implemented measures to mitigate these risks[16]. - The company faces significant risk due to a high revenue concentration from core customers, particularly in overseas markets, which could impact sales if these customers reduce orders[107]. - To mitigate risks from core customer reliance, the company plans to actively explore new markets and maintain strong relationships with existing clients, while enhancing product offerings[108]. - Fluctuations in raw material prices, such as hides and chicken, pose a risk to operational costs; however, the company has not experienced significant price volatility recently[109]. - The ongoing COVID-19 pandemic continues to pose risks to production and logistics, potentially impacting overall performance[115]. Sustainability and Social Responsibility - The company is focusing on sustainability initiatives, aiming to reduce carbon emissions by 15% by 2025[16]. - The company maintains a robust environmental management system and is committed to building green, low-carbon, and efficient pet food factories[131]. - The company has implemented wastewater treatment systems to ensure that production and domestic wastewater meet discharge standards before being released into the municipal sewage system[132]. - The company emphasizes its commitment to social responsibility, promoting a healthy pet culture and providing safe, healthy products to meet diverse consumer needs[134]. Shareholder and Financial Management - No cash dividends or stock bonuses will be distributed to shareholders for this period[6]. - The company did not distribute cash dividends or issue new shares during the reporting period[127]. - The company has extended the share repurchase plan until March 23, 2023, with ongoing repurchase activities since March 29, 2022[166]. - The company has repurchased a total of 4,028,135 shares, accounting for 1.5896% of the total share capital as of July 2022[169]. - The company issued convertible bonds with a total amount of 720,000,000.00 CNY, netting 711,859,782.01 CNY after deducting related fees[172]. Industry Trends and Market Insights - The global pet industry has shown significant growth, with increasing consumer spending on pet-related products and services, reflecting a robust market environment[46]. - The pet food market in China is experiencing a shift towards health, personalization, and diversification, with consumers increasingly prioritizing nutritional balance and ingredient quality[51]. - The pet food industry in China reached a scale of 249 billion RMB in 2021, growing by 20.58% compared to 2020, with a compound annual growth rate of 24.88% from 2012 to 2021[67]. - The pet ownership rate in China was approximately 17% in 2019, significantly lower than the U.S. rate of 67%, indicating substantial growth potential[55]. - The rise of short video platforms is driving growth in the pet industry, with significant engagement from pet owners on platforms like Kuaishou, where pet-related content has seen a 32% increase in production since 2019[54].